GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

G&E Herbal Biotechnology Co 4911.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

25.30

+1.20%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About G&E Herbal Biotechnology Co

Its shares trade on Taipei Exchange under the ticker 4911.TWO. It has been listed since 28 April 2008. In the fiscal year to 31 December 2025, it reported revenue of TWD 309.1m and net income of TWD 139.2m. At that date it held total assets of TWD 975.2m and shareholders' equity of TWD 928.1m.

G&E Herbal Biotechnology Co., Ltd. is engaged in the development, manufacture, and sale of novel botanic drugs, western & herbal medicines. The company is headquartered in Tainan, Tainan. The company went IPO on 2008-04-28. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The firm also provides botanical medicines for cancers and liver diseases. The firm distributes its products within domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
28 Apr 2008
Employees
30

Leadership

Pay as last reported

  • Guohua GuoChairman of the Board, Chief Executive Officer-Product Quality, General Manager, since 2002TWD 2.8m
  • Nafen ZhangCorporate Governance Officer
  • Zhangyi HongHead of Finance & Accounting
  • Ms. Shuwen WuDirector
  • Mr. Junnong HuangIndependent Director
  • Mr. Liwei LinIndependent Director
  • Mr. Nenghui LinIndependent Director
  • Mr. Zhicong LinIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Tainan, Taiwan
  • Operates in the Consumer Staples sector
  • Offers products including novel botanic drugs and herbal medicines

Weaknesses

  • Limited to domestic and overseas markets without specific market share details
  • No mention of product innovation beyond current offerings
  • Small employee count of 30 staff members

Opportunities

  • Expansion into new markets for health care food products
  • Growth potential in herbal medicine demand
  • Potential for increased international distribution

Threats

  • Dependence on domestic market for product distribution
  • Unspecified competition in the herbal medicine sector
  • Lack of detailed financial data for risk assessment

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.